Phase 3, randomized, double-blind, placebo-controlled study of pembrolizumab plus chemotherapy in patients with HR+/HER2-locally recurrent inoperable or metastatic breast cancer (mBC): KEYNOTE-B49

Schmid P., Sohn J. H., Jerez Gilarranz Y., Gonzalez-Cortijo L., Sonnenblick A., Sabanathan D., ...More

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol.18, pp.233-234, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 18
  • Publication Date: 2022
  • Journal Name: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Page Numbers: pp.233-234
  • Hacettepe University Affiliated: Yes